Patología Molecular de las enfermedades raras
PatMol-ER
Universidad Autónoma de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (30)
2024
-
Clinical Characteristics of Patients With Acquired Partial Lipodystrophy: A Multicenter Retrospective Study
The Journal of clinical endocrinology and metabolism, Vol. 109, Núm. 3, pp. e932-e944
2023
-
Characterization and Clinical Association of Autoantibodies Against Perilipin 1 in Patients With Acquired Generalized Lipodystrophy
Diabetes, Vol. 72, Núm. 1, pp. 71-84
2022
-
MicroRNA-4732-3p Is Dysregulated in Breast Cancer Patients with Cardiotoxicity, and Its Therapeutic Delivery Protects the Heart from Doxorubicin-Induced Oxidative Stress in Rats
Antioxidants, Vol. 11, Núm. 10
-
Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trial
BMC Cardiovascular Disorders, Vol. 22, Núm. 1
2021
-
Complement factor d (Adipsin) levels are elevated in acquired partial lipodystrophy (barraquer–simons syndrome)
International Journal of Molecular Sciences, Vol. 22, Núm. 12
2020
-
Correction: Immunological features of patients affected by Barraquer-Simons syndrome (Orphanet Journal of Rare Diseases DOI: 10.1186/s13023-019-1292-1)
Orphanet Journal of Rare Diseases
-
Dietary magnesium supplementation improves lifespan in a mouse model of progeria
EMBO Molecular Medicine, Vol. 12, Núm. 10
-
Evidence of ongoing complement activation on adipose tissue from an 11-year-old girl with Barraquer–Simons syndrome
Journal of Dermatology, Vol. 47, Núm. 12, pp. 1439-1444
-
Immunological features of patients affected by Barraquer-Simons syndrome
Orphanet Journal of Rare Diseases, Vol. 15, Núm. 1
-
Redox theory in progeria
Aging, Vol. 12, Núm. 21, pp. 20934-20935
2019
-
ATP-based therapy prevents vascular calcification and extends longevity in a mouse model of Hutchinson–Gilford progeria syndrome
Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Núm. 47, pp. 23698-23704
-
New treatments for progeria
Aging
-
Questioning the safety of calcidiol in hemodialysis patients
Nutrients, Vol. 11, Núm. 5
2018
-
Autoantibodies against perilipin 1 as a cause of acquired generalized lipodystrophy
Frontiers in Immunology, Vol. 9, Núm. SEP
-
Role of pyrophosphate in vascular calcification in chronic kidney disease
Nefrologia
2017
-
A decrease in intact parathyroid hormone (iPTH) levels is associated with higher mortality in prevalent hemodialysis patients
PLoS ONE, Vol. 12, Núm. 3
-
Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia
Journal of Clinical Lipidology, Vol. 11, Núm. 1, pp. 260-271
-
Differences between 2nd and 3rd generation seric parathormone determination methods on mortality in haemodialysis patients
Nefrologia, Vol. 37, Núm. 4, pp. 389-396
-
Phosphate, pyrophosphate, and vascular calcification: A question of balance
European Heart Journal
-
Réplica a «Tratamiento de la hiperuricemia asintomática»
Revista Clinica Espanola